Literature DB >> 16984530

Esophageal cancer after distal gastrectomy.

N Hashimoto1, M Inayama, M Fujishima, H Ho, M Shinkai, N Hirai, K Kawanishi, M Imano, H Shigeoka, H Imamoto, H Shiozaki.   

Abstract

The effect of gastrectomy on the subsequent development of esophageal cancer was investigated. Duodenogastroesophageal reflux is thought to be common in patients after distal gastrectomy, but whether this contributes to the development of esophageal cancer in such patients is controversial. We retrospectively evaluated 153 patients who underwent subtotal esophagectomy for thoracic esophageal cancer between January 2002 and July 2005. They were divided into two groups, according to whether or not they had previously undergone a gastrectomy: group 1, comprising 14 patients who had undergone gastrectomy and group 2, comprising 139 patients who had not. Clinical profiles of the patients were obtained from the medical records and the whole resected esophagus was histopathologically examined. The interval between gastrectomy and esophagectomy in group 1 was significantly shorter in the patients who had undergone gastrectomy for gastric cancer (10.5 +/- 4.2 years) than in those who had undergone gastrectomy for a peptic ulcer (28.9 +/- 3.0 years). The interval was also somehow shorter in the patients for whom anastomosis had been performed by Billroth I (21.3 +/- 5.6 years) compared with Billroth II (29.7 +/- 3.2 years), although the difference did not reach its statistical significance (P = 0.11). Moreover, the proportion of lower third tumors in patients after gastrectomy was significantly higher compared with that of the patients with intact stomach. These findings suggest that a history of gastrectomy is associated with more lower-third squamous cell esophageal carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16984530     DOI: 10.1111/j.1442-2050.2006.00599.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

1.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Esophagogastric reconstruction using remnant stomach with a single vessel pedicel: Technique and outcomes.

Authors:  Bin You; Sheng-Cai Hou; Hui Li; Bin Hu
Journal:  Thorac Cancer       Date:  2014-03-03       Impact factor: 3.500

Review 3.  Controversy surrounding 'mini' gastric bypass.

Authors:  Kamal K Mahawar; William R J Carr; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

4.  Surgical treatment and prognosis of esophageal cancer after distal gastrectomy.

Authors:  Lihui Wu; Zhifei Xu; Xuewei Zhao; Jianqiu Li; Yaochang Sun
Journal:  J Gastrointest Surg       Date:  2009-09-15       Impact factor: 3.452

5.  Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.

Authors:  Jing Hao; Ba Liu; Chung S Yang; Xiaoxin Chen
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

Review 6.  Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma.

Authors:  Ali Soroush; Arash Etemadi; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2021-07-08       Impact factor: 3.487

7.  Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.

Authors:  Sho Sato; Hiroto Yamamoto; Ken-Ichi Mukaisho; Shota Saito; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

8.  Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan.

Authors:  H Okumura; N Mori; T Tanaka; M Morita; Y Toh; H Saeki; Y Maehara; K Nakamura; H Honda; N Yoshida; H Baba; S Natsugoe
Journal:  Dis Esophagus       Date:  2015-11-06       Impact factor: 3.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.